This annex is the result of the Q4B process for the Tablet Fragibility General Chapter. The proposed texts were submitted by the Pharmacopoeial Discussion Group. It aims to facilitate the recognition by regulatory authorities of pharmacopoeial analytical procedures and acceptance criteria relating to tablet friability for use in the ICH regions.

Keywords: Tablet friability, pharmacopoeia

Current effective version

Document history - First version (current)

Share this page